SURF1 and Leigh syndrome: In 2021, our group reported the development of such a therapy delivered by AAV serotype 9 (AAV9) for SURF1-related Leigh syndrome, in which a codon-optimized human SURF1 (hSURF1opt) gene was expressed (AAV9/hSURF1v1) to restore the function of SURF1.12